a new oral drug for leukemia called Tasigna

December 2007

You'll hear about a new oral drug for leukemia called Tasigna.

Tasigna (nilotinib) is an oral kinase inhibitor...similar to Gleevec (imatinib) or Sprycel (dasatinib).

Tasigna and Sprycel are for cases that are resistant to Gleevec.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote